Trinity Biotech PLC (TRIB)
1.83
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 16:00
1.85
+0.02
(+1.09%)
After-Hours: 20:00
Trinity Biotech Cash from Operations (TTM): -9.968M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -9.968M |
June 30, 2023 | -4.628M |
March 31, 2023 | -2.146M |
December 31, 2022 | -0.921M |
September 30, 2022 | 1.578M |
June 30, 2022 | 2.599M |
March 31, 2022 | 5.662M |
December 31, 2021 | 13.24M |
September 30, 2021 | 21.38M |
June 30, 2021 | 26.72M |
March 31, 2021 | 31.23M |
December 31, 2020 | 23.76M |
September 30, 2020 | 7.644M |
June 30, 2020 | 5.246M |
March 31, 2020 | 4.549M |
December 31, 2019 | 5.417M |
September 30, 2019 | 11.03M |
June 30, 2019 | 9.333M |
March 31, 2019 | 5.918M |
December 31, 2018 | 7.229M |
September 30, 2018 | 6.76M |
June 30, 2018 | 7.897M |
March 31, 2018 | 9.797M |
December 31, 2017 | 9.25M |
September 30, 2017 | 8.751M |
Date | Value |
---|---|
June 30, 2017 | 10.07M |
March 31, 2017 | 8.83M |
December 31, 2016 | 10.23M |
September 30, 2016 | 17.04M |
June 30, 2016 | 14.12M |
March 31, 2016 | 12.92M |
December 31, 2015 | 13.16M |
September 30, 2015 | 14.23M |
June 30, 2015 | 16.98M |
March 31, 2015 | 17.14M |
December 31, 2014 | 16.06M |
September 30, 2014 | 7.592M |
June 30, 2014 | 5.792M |
March 31, 2014 | 7.082M |
December 31, 2013 | 9.357M |
September 30, 2013 | 14.81M |
June 30, 2013 | 16.84M |
March 31, 2013 | 19.25M |
December 31, 2012 | 19.96M |
September 30, 2012 | 18.34M |
June 30, 2012 | 18.00M |
March 31, 2012 | 18.23M |
December 31, 2011 | 20.46M |
September 30, 2011 | 23.56M |
June 30, 2011 | 23.72M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-9.968M
Minimum
Sep 2023
31.23M
Maximum
Mar 2021
8.429M
Average
5.540M
Median
Cash from Operations (TTM) Benchmarks
Amarin Corp PLC | 6.88M |
Avadel Pharmaceuticals PLC | -128.51M |
DBV Technologies SA | -79.65M |
Adaptimmune Therapeutics PLC | -140.88M |
Akari Therapeutics PLC | -- |